Table 3.
Study (Author/year) | Number of patients | Wide resection | Intralesional curettage | Intralesional curettage + regional burring | Intralesional curettage + PMMA |
---|---|---|---|---|---|
Klenke et al. 2011 [35] | 118 | 5 | N/A | 32 | + phenol + burrin:15 |
Errani et al. 2010 [32] | 349 | 12 | N/A | 18 | |
Balke et al. 2008 [37] | 214 | 0 | 140 | 47 | +phenol: 38 |
Kivioja et al. 2008 [11] | 294 | 12 | 51 | N/A | 22 |
Knochentumoren 2008 [52] | 256 | 2 | 49 | N/A | +phenol:69 |
Malek et al. 2006 [56] | 40 | N/A | N/A | 33 | N/A |
McGough et al. 2005 [57] | 183 | N/A | 46 | N/A | N/A |
Prosser et al. 2005 [40] | 137 | 0 | N/A | N/A | +burring: 21 |
Su et al. 2004 [41] | 87 | 3 | N/A | N/A | +phenol: 18 |
Turcotte et al. 2002 [55] | 186 | 34 | N/A | N/A | +phenol + burring:55 |
Blackley et al. 1999 [43] | 59 | N/A | N/A | 12 | N/A |
Campanacci et al. 1987 [1] | 280 | 0 | 27 | N/A | 8 |
McDonald 1986 [45] | 146 | 7 | N/A | 34 | N/A |
Results from the current literature implies that the recurrence ratio of GCT is: Intralesional curettage > Intralesional curettage + regional burring > Intralesional curettage + local adjuvants + PMMA > Wide resection.